Matches in SemOpenAlex for { <https://semopenalex.org/work/W3048512073> ?p ?o ?g. }
- W3048512073 endingPage "9730" @default.
- W3048512073 startingPage "9705" @default.
- W3048512073 abstract "Muscle atrophy and cachexia are common comorbidities among patients suffering from cancer, chronic obstructive pulmonary disease, and several other chronic diseases. The peptide hormone ghrelin exerts pleiotropic effects including the stimulation of growth hormone secretion and subsequent increase of insulin-like growth factor-1 levels, an important mediator of muscle growth and repair. Ghrelin also acts on inflammation, appetite, and adipogenesis and therefore has been considered a promising therapeutic target for catabolic conditions. We previously reported on the synthesis and properties of an indane based series of ghrelin receptor full agonists which led to a sustained increase of insulin-like growth factor-1 in a dog pharmacodynamic study. Herein we report on the identification of a series of pyrrolidine or piperidine based full agonists and attempted optimization to give compounds with profiles suitable for progression as clinical candidates." @default.
- W3048512073 created "2020-08-18" @default.
- W3048512073 creator A5006288125 @default.
- W3048512073 creator A5013273787 @default.
- W3048512073 creator A5015059001 @default.
- W3048512073 creator A5021417625 @default.
- W3048512073 creator A5024033575 @default.
- W3048512073 creator A5026773546 @default.
- W3048512073 creator A5037424601 @default.
- W3048512073 creator A5039208792 @default.
- W3048512073 creator A5039394959 @default.
- W3048512073 creator A5041272388 @default.
- W3048512073 creator A5048005288 @default.
- W3048512073 creator A5062346266 @default.
- W3048512073 creator A5065412015 @default.
- W3048512073 creator A5067415005 @default.
- W3048512073 creator A5073858751 @default.
- W3048512073 creator A5075887120 @default.
- W3048512073 creator A5087536351 @default.
- W3048512073 creator A5091216413 @default.
- W3048512073 creator A5091886214 @default.
- W3048512073 date "2020-08-12" @default.
- W3048512073 modified "2023-10-17" @default.
- W3048512073 title "Identification and Optimization of Pyrrolidine Derivatives as Highly Potent Ghrelin Receptor Full Agonists" @default.
- W3048512073 cites W1933769942 @default.
- W3048512073 cites W1968472186 @default.
- W3048512073 cites W1975317427 @default.
- W3048512073 cites W1977122152 @default.
- W3048512073 cites W1981927821 @default.
- W3048512073 cites W1998015067 @default.
- W3048512073 cites W2002886956 @default.
- W3048512073 cites W2012465610 @default.
- W3048512073 cites W2016710361 @default.
- W3048512073 cites W2020482447 @default.
- W3048512073 cites W2029984878 @default.
- W3048512073 cites W2034697008 @default.
- W3048512073 cites W2037548155 @default.
- W3048512073 cites W2049105371 @default.
- W3048512073 cites W2058732924 @default.
- W3048512073 cites W2062458432 @default.
- W3048512073 cites W2064747164 @default.
- W3048512073 cites W2067559257 @default.
- W3048512073 cites W2075205895 @default.
- W3048512073 cites W2076552452 @default.
- W3048512073 cites W2079011273 @default.
- W3048512073 cites W2092286450 @default.
- W3048512073 cites W2093673377 @default.
- W3048512073 cites W2125211085 @default.
- W3048512073 cites W2144623624 @default.
- W3048512073 cites W2161035962 @default.
- W3048512073 cites W2165699357 @default.
- W3048512073 cites W2171358387 @default.
- W3048512073 cites W2506776793 @default.
- W3048512073 cites W2619897972 @default.
- W3048512073 cites W2791224496 @default.
- W3048512073 cites W2808361266 @default.
- W3048512073 cites W2892549463 @default.
- W3048512073 cites W2903396202 @default.
- W3048512073 cites W2912818999 @default.
- W3048512073 cites W2914754420 @default.
- W3048512073 cites W4211061743 @default.
- W3048512073 cites W70782241 @default.
- W3048512073 doi "https://doi.org/10.1021/acs.jmedchem.0c00828" @default.
- W3048512073 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32787075" @default.
- W3048512073 hasPublicationYear "2020" @default.
- W3048512073 type Work @default.
- W3048512073 sameAs 3048512073 @default.
- W3048512073 citedByCount "9" @default.
- W3048512073 countsByYear W30485120732021 @default.
- W3048512073 countsByYear W30485120732022 @default.
- W3048512073 crossrefType "journal-article" @default.
- W3048512073 hasAuthorship W3048512073A5006288125 @default.
- W3048512073 hasAuthorship W3048512073A5013273787 @default.
- W3048512073 hasAuthorship W3048512073A5015059001 @default.
- W3048512073 hasAuthorship W3048512073A5021417625 @default.
- W3048512073 hasAuthorship W3048512073A5024033575 @default.
- W3048512073 hasAuthorship W3048512073A5026773546 @default.
- W3048512073 hasAuthorship W3048512073A5037424601 @default.
- W3048512073 hasAuthorship W3048512073A5039208792 @default.
- W3048512073 hasAuthorship W3048512073A5039394959 @default.
- W3048512073 hasAuthorship W3048512073A5041272388 @default.
- W3048512073 hasAuthorship W3048512073A5048005288 @default.
- W3048512073 hasAuthorship W3048512073A5062346266 @default.
- W3048512073 hasAuthorship W3048512073A5065412015 @default.
- W3048512073 hasAuthorship W3048512073A5067415005 @default.
- W3048512073 hasAuthorship W3048512073A5073858751 @default.
- W3048512073 hasAuthorship W3048512073A5075887120 @default.
- W3048512073 hasAuthorship W3048512073A5087536351 @default.
- W3048512073 hasAuthorship W3048512073A5091216413 @default.
- W3048512073 hasAuthorship W3048512073A5091886214 @default.
- W3048512073 hasConcept C121608353 @default.
- W3048512073 hasConcept C126322002 @default.
- W3048512073 hasConcept C134018914 @default.
- W3048512073 hasConcept C170493617 @default.
- W3048512073 hasConcept C185592680 @default.
- W3048512073 hasConcept C2777704314 @default.
- W3048512073 hasConcept C2779168441 @default.
- W3048512073 hasConcept C2779357093 @default.